Comparing of Supervised and Unsupervised Home-Based Modified Poco-Poco Exercise in Elderly

May 23, 2026 updated by: Irma Ruslina Defi, Universitas Padjadjaran

Comparing of Supervised and Unsupervised Home-Based Modified Poco-Poco Exercise in Elderly: Effects on Sarcopenia Status, Quality of Life and Loneliness

This study comparing 2 group of intervention which are supervised home-based therapy (intervention group) and unsupervised home-based therapy (control group) using a modified poco-poco exercise program as the home-based therapy.

Study Overview

Study Type

Interventional

Enrollment (Actual)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • West Java
      • Bandung, West Java, Indonesia
        • Griya Antapani Community Centre
      • Bandung, West Java, Indonesia
        • Sekejati Community Health Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Age above 60 years old
  2. Have sarcopenia (based on AWGSOP 2019 criteria)
  3. MoCA INA score ≥ 18
  4. Low loneliness level (>20) in UCLA
  5. Participants or caregiver must have a communication device that can play video and zoom application

Exclusion Criteria:

  1. Hearing impairment/loss hindering participants to receive instructions
  2. Vision impairment/loss hindering participants to receive instructions 24
  3. Musculoskeletal impairment hindering participants to do exercise
  4. Participants have been involved in other exercise program (exercise is defined as moderate-intensity activities, accumulate at least 30 minutes a day in bouts of at least 10 minutes each to total 150-300 minutes a week, or at least 20 minutes a day or more of vigorous-intensity activities to total 75-150 minutes a week) for the last 2 weeks
  5. Severe joint diseases (i.e deformity in Osteoarthritis or Rheumatoid Arthritis) that can get worsen after exercise or hindering participants to do exercise
  6. Severe cardiovascular disease diagnosed by Cardiologist

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group
Supervised home-based therapy
Patient will do the exercise at home 5 days/week and supervised via zoom application. Supervised via Zoom will be conducted every week. The instructor will monitor the exercise movement of the participants, if there is any mistake the instructor will pause the session and correct it immediately. The monitoring will also be done by researcher assistant to collect attendance, help ensure correct movement and operational problem. The intensity of the exercise will be evaluated and adjusted every 4 weeks.
Experimental: Control Group
Unsupervised home-based therapy
Patient will do the exercise at home 5 days/week and supervised via zoom application. Supervised via Zoom will be conducted every week. The instructor will monitor the exercise movement of the participants, if there is any mistake the instructor will pause the session and correct it immediately. The monitoring will also be done by researcher assistant to collect attendance, help ensure correct movement and operational problem. The intensity of the exercise will be evaluated and adjusted every 4 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of Life that are given supervised home-based modified poco-poco exercise better compared to unsupervised home-based modified poco-poco exercise
Time Frame: 12 weeks
Using Sarcopenia Quality of Life (SARQOL) - Score in number 0-100
12 weeks
Loneliness of the elderly with sarcopenia that are given supervised home-based modified poco-poco exercise better compared to unsupervised home-based modified poco-poco exercise
Time Frame: 12 weeks
Using UCLA Loneliness Scale (Score in number:20-80)
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2025

Primary Completion (Actual)

September 1, 2025

Study Completion (Actual)

September 1, 2025

Study Registration Dates

First Submitted

June 11, 2025

First Submitted That Met QC Criteria

June 11, 2025

First Posted (Actual)

June 19, 2025

Study Record Updates

Last Update Posted (Actual)

May 27, 2026

Last Update Submitted That Met QC Criteria

May 23, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IKFR.11.06.25

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Geriatrics Rehabilitation

Clinical Trials on Modified poco-poco exercise program as the home-based therapy (Intervention)

Subscribe